A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: a review on the emerging data

Rana K, Reid J, Rosenwasser JN, Lewis T, Sheikh-Ali M, Choksi RR, Goldfaden RF

Diabetes, Metabolic Syndrome and Obesity 2019, 12:1897-1911

Published Date: 19 September 2019